Jakarta, Feb. 5 -- The Food and Drug Supervisory Agency (BPOM) has decided to shorten the certification process for innovative drugs from 300 working days to 90 days to support cancer treatment.

BPOM head Taruna Ikrar said here on Wednesday that cancer drugs are among innovative products.

"If the certification process is quick and we can produce the raw materials domestically, the prices will decline," he told the press.

In addition, the BPOM will include the retail price ceiling to ensure the prices are not manipulated.

According to Ikrar, the current challenge is that the research, development, and clinical trials of cancer treatment are still very costly.

Earlier, the Indonesian government said that it has created the 2024-2034 Na...